Chemoinformaics analysis of 2-Trans-6-Trans-Piperamide-C-7-2
| Molecular Weight | 299.37 | nRot | 5 |
| Heavy Atom Molecular Weight | 278.202 | nRig | 18 |
| Exact Molecular Weight | 299.152 | nRing | 3 |
| Solubility: LogS | -4.378 | nHRing | 2 |
| Solubility: LogP | 3.685 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 43 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 47.5687 |
| nHD | 0 | BPOL | 27.1173 |
| QED | 0.618 |
| Synth | 2.459 |
| Natural Product Likeliness | 0.375 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.979 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -4.725 |
| MDCK | 0.0000275 |
| BBB | 0.303 |
| PPB | 0.97258 |
| VDSS | 0.777 |
| FU | 0.0279833 |
| CYP1A2-inh | 0.976 |
| CYP1A2-sub | 0.602 |
| CYP2c19-inh | 0.841 |
| CYP2c19-sub | 0.44 |
| CYP2c9-inh | 0.436 |
| CYP2c9-sub | 0.739 |
| CYP2d6-inh | 0.924 |
| CYP2d6-sub | 0.909 |
| CYP3a4-inh | 0.935 |
| CYP3a4-sub | 0.234 |
| CL | 11.33 |
| T12 | 0.689 |
| hERG | 0.404 |
| Ames | 0.004 |
| ROA | 0.033 |
| SkinSen | 0.978 |
| Carcinogencity | 0.687 |
| EI | 0.408 |
| Respiratory | 0.97 |
| NR-Aromatase | 0.293 |
| Antiviral | Yes |
| Prediction | 0.688925 |